Phamatech in the News | Press Releases
January, 2008
San Diego, CA – Phamatech has received California Clinical Laboratory License and Clinical Laboratories Improvement Act (CLIA) certification
Phamatech Laboratories and Diagnostics is pleased to expand our laboratory toxicology services into the clinical area with state licensure and federal certification. Clinical testing, defined as testing for the diagnosis, assessment or treatment of disease, is distinguished from chain of custody forensic testing providing legal defensibility. In addition to our SAMHSA certification for forensic urine drug testing, the clinical licenses allows Phamatech laboratories to better serve all toxicology testing needs of our clients, whether on-site, clinical, treatment, probation and parole, or workplace.
“We have been successful in growing our company by providing products and services that are accurate, cost effective and built to the highest standards of quality,” said Phamatech President and CEO Tuan Pham, Ph.D. “The addition of our California Clinical and CLIA laboratory certification will allow us to reach different segments of the drugs-of-abuse test markets and will be a critical part of our growth strategy over the next few years.”
Phamatech Laboratories and Diagnostics is a leading manufacturer of CLIA waived and FDA cleared diagnostic devices for direct to consumer testing, including Clear Choice© Pregnancy Tests, AtHome© Drug Test devices, and QuickScreen© Cup and Card drug testing devices. With the addition of our laboratory services, Phamatech provides a unique and complete solution for your testing needs. |
